Results 11 to 20 of about 11,363 (224)

Antioxidant and Hypolipidemic Activities of Cinnamic Acid Derivatives

Molecules, 2023
Oxidative stress and hyperlipidemia are important factors for the initiation and progression of various cell degenerative pathological conditions, including cardiovascular and neurological diseases.
Christina Nouni, Panagiotis Theodosis-Nobelos, Eleni A. Rekka   +2 more
doaj   +2 more sources

MODELING OF MICE AS TEST ANIMALS FOR A PRECLINICAL STUDY OF HYPOLIPIDEMIC AGENTS

Jurnal Farmasi Sains dan Praktis, 2023
Animal models suitable for preclinical research are necessary for the discovery of hypolipidemic agents. Various publications have presented alternative dyslipidemia animal models, but identifying a feasible and stable method would serve as a solid ...
Setiyo Budi Santoso, Widarika Santi Hapsari, Renny Setyowati   +2 more
doaj   +3 more sources

A Proof-of-Concept for a Hypolipidemic Brown Trout Model

Toxics
The impacts of hypolipidemic pharmaceuticals on fish lipid metabolism remain unexplored. However, data points to similar effects and mechanisms of action between fish and humans.
Tiago Lourenço, Eduardo Rocha, José Fernando Gonçalves, Maria João Rocha, Tânia Vieira Madureira   +4 more
doaj   +2 more sources

Hypolipidemic Effects of β-Glucans, Mannans, and Fucoidans: Mechanism of Action and Their Prospects for Clinical Application

Molecules, 2020
The search for lipid-lowering drugs is important for clinical medicine. This review summarizes our research findings regarding the hypolipidemic activity of polysaccharides.
Tatiana A. Korolenko, Nataliya P. Bgatova, Marina V. Ovsyukova, Alexandra Shintyapina, Vaclav Vetvicka   +4 more
doaj   +2 more sources

Hypolipidemic effect of Silymarin in Dyslipidaemia of Different Etiologies

مجلة كلية الطب, 2008
Background: Many drug and non drug approaches are utilized for the treatment of dyslipidemia; flavonoids, the major constituents of silymarin, have been proved to positively modify lipoproteins in experimentally – induced dyslipidemia.
Bahir Abdul Razzaq Mesheimish, Saad Abdul-Rehman Hussain, Sajida Hussein Ismail, Khalid Brahmani Hussein, Amaal Ajaweed Sulaiman   +4 more
doaj   +2 more sources

Assessing the adherence to and the therapeutic effectiveness of hypolipidemic agents in a population of patients in Brazil: a retrospective cohort study. [PDF]

Pharm Pract (Granada), 2014
Objective: to evaluate the relation between patient adherence and therapeutic effectiveness of hypolipidemic agents in clinical practice. Methods: A retrospective cohort study of 417 patients using hypolipidemic drugs (simvastatin, atorvastatin) between
Cunico C, Picheth G, Correr CJ, Scartezini M.   +3 more
europepmc   +2 more sources

Terapia hipolipemiante em situações especiais: hipotireoidismo e hepatopatias Hypolipidemic therapy in special situations: hypothyroidism and liver disease

Arquivos Brasileiros de Cardiologia, 2005
O hipotireoidismo é comum entre pessoas idosas, especialmente entre as mulheres. A suspeita diagnóstica deve se basear na presença de sinais e sintomas clássicos e a detecção pode ser feita pela elevação dos níveis do hormônio tireo-estimulante (TSH ...
Fernando H. Y. Cesena, Hermes Toros Xavier, Protásio L. da Luz   +2 more
doaj   +2 more sources

Associations between education level, blood-lipid measurements and statin treatment in a Danish primary health care population from 2000 to 2018

Scandinavian Journal of Primary Health Care, 2023
Objective To examine whether education level influences screening, monitoring, and treatment of hypercholesterolemia.Design Epidemiological cohort study.Setting Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre.Subjects ...
Marius Mølsted Flege, Margit Kriegbaum, Henrik Løvendahl Jørgensen, Bent Struer Lind, Lise Bathum, Christen Lykkegaard Andersen, Anna Elise Engell   +6 more
doaj   +1 more source

Extreme lipoprotein(a) in clinical practice: A cross sectional study

International Journal of Cardiology. Cardiovascular Risk and Prevention, 2023
Introduction: Measurement of lipoprotein(a) [Lp(a)] is recommended once in a lifetime to identify individuals at high risk of atherosclerotic cardiovascular disease (ASCVD).
Barak Zafrir, Amir Aker, Walid Saliba
doaj   +1 more source

PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines

Безопасность и риск фармакотерапии, 2023
Scientific relevance. Cardiovascular diseases (CVD) are the leading cause of death worldwide. Dyslipidemia, as the pathophysiological basis of atherosclerosis, is the most important cause of CVD.
A. A. Nekipelova, R. N. Alyautdin
doaj   +1 more source